Built to deliver predictable results in synthesis routines, this Separation column for HPLC, specifically the HPLC column NUCLEOSHELL ® RP 18, boasts a high density C 18 phase based on core-shell technology silica gel particles. Its endcapping feature suppresses any unwanted polar interactions between the silica surface and the sample, making it ideal for separating basic and other ionizable analytes. With enhanced pH stability, LC/MS suitability, and superior base deactivation, it expedites RP applications. Featuring a particle size of 2.7 μm, this analytical separation column is suitable for a wide range of applications including antibiotics, antidepressants, anti-inflammatory drugs, herbicides, immunosuppressants, phytopharmaceuticals, and is compatible with LC-MS analys

• Category: Separation columns for HPLC
• Phase: RP 18
• pH stability: 1,0-11,0
• Specific surface according to BET: 90 m²/g
• Column shape: Analytical separation column
• Endcapped: yes
• Particle type: Core-shell, superficially porous particles (SPP)
• Particle size: 2.7 µm
• L x Ø internal (column): 50 x 4 mm
• USP listing: L1
• Surface chemistry: High density monomeric octadecyl (C 18 , ODS) modification, Base deactivated (BDS)
• Column type: HPLC column
• Column volume: 0.62 ml
• Pore volume: 0.9 ml/g
• Pore size: 90 Å
• Eluent in column: Acetonitrile - Water
• Pressure stability: 600 bar
• Interactions / retention mechanism: hydrophobic (van der Waals)
• Separation principle: Reversed phase (RP)
• Recommended application(s): Antibiotics Antidepressants Anti-inflammatory drugs Herbicides Immunosuppressants Phytopharmaceuticals Suitable for LC-MS
• Application Database (Macherey-Nagel): HPLC
• Temperature stability: 60 ° C